Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CoStim Pharmaceuticals

Request full access

Hard facility management

Boston, United StatesFounded 2011Biotech & Life Sciences

About CoStim Pharmaceuticals

COSTIM is a Real Estate developer with an industrial profile, operating throughout the national territory. The company specializes in major urban regeneration projects, both its own and for third parties, based on the ChorusLife concept—a human-centric prototype. The first example of this concept is currently being completed in Bergamo, with two new projects in the planning stages and a significant pipeline of similar initiatives underway.

The industrial expertise of the COSTIM Group is supported by leading market operators in their respective segments: Impresa Percassi, one of the top general contractors in the private construction sector; Gualini, specializing in the design and manufacture of construction envelopes; and Elmet, a global service and energy service company (ESCo).

COSTIM leverages digitization and innovation through its proprietary digital platform, GSM, to offer state-of-the-art solutions for urban transformation. These solutions are guided by measurable sustainability criteria and focus on enhancing user experience and well-being. The company positions itself as a reliable partner for stakeholders and investors, aiming to deliver results throughout the entire design stage—from conception to planning, implementation, and subsequent management.

Source: Dealroom company data

CoStim Pharmaceuticals in the Boston ecosystem

Live from Dealroom

The CoStim Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • MPM BioImpact

Series A2 investors entered at this stage

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇮🇹 Italy98.2%
🇫🇷 France1.8%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CoStim Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CoStim Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.